Else Nutrition Applauds Pivotal U.S. Legislative Support for Plant-Based, Non-Soy, Non-Dairy Infant Formula Innovation

Stock Information for Intermap Technologies Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Intermap Technologies Corporation

Else Nutrition Achieves Transformative Operational and Financial Progress in 2025
ELSE NUTRITION ANNOUNCES FURTHER EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
Else Nutrition CEO to Present at Investor Summit Virtual on December 9, 2025
Else Nutrition Secures Five-Year Renewal of Israel's Largest Health Fund Tender for Baby Feeding Solutions
ELSE ANNOUNCES INVESTMENT FOR GROSS PROCEEDS OF UP TO US$1,280,000
Else Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based Infant Formula
Else Nutrition Reports Significant Operational Turnaround in Q3 2025 with Gross Margin Expansion and Cost Reduction
Else Nutrition Reschedules 2025 Third Quarter Business Update Conference Call

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.